Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Diabetes and Metabolic Disorders|August 25, 2020
Drug repurposing using computational methods to identify therapeutic options for COVID-19Soodeh Mahdian, Azadeh Ebrahim-Habibi, Mahboobeh ZarrabiGenomics|July 28, 2022
Insights from cyanobacterial genomic and transcriptomic analyses into adaptation strategies in terrestrial environmentsFatemeh Khani-Juyabad, Parisa Mohammadi, Mahboobeh ZarrabiComputational Biology and Chemistry|October 29, 2025
Comparative in silico analysis identifies potent natural and synthetic peptide candidates for targeting SARS-CoV-2 viral proteinsSara Mortezaali, Fatemeh Ebrahimi Tarki, Mahboobeh ZarrabiJournal of Diabetes and Metabolic Disorders|November 16, 2023
Correction to: Drug repurposing using computational methods to identify therapeutic options for COVID-19Soodeh Mahdian, Azadeh Ebrahim-Habibi, Mahboobeh ZarrabiInformatics in Medicine Unlocked|March 2, 2021
Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsSoodeh Mahdian, Mahboobeh Zarrabi, Yunes Panahi, et al.Physical Chemistry Chemical Physics : PCCP|August 5, 2026
Lipidomic adaptation and membrane physical changes underlie tamoxifen resistance in breast cancer: molecular dynamics simulation studyElahe Hoseinnia, Fatemeh Ebrahimi Tarki, Mahboobeh Zarrabi, et al.Iranian Journal of Pharmaceutical Research : IJPR|March 7, 2024
Integration of Machine Learning and Structural Analysis for Predicting Peptide Antibiofilm Effects: Advancements in Drug Discovery for Biofilm-Related InfectionsFatemeh Ebrahimi Tarki, Mahboobeh Zarrabi, Ahya Abdiali, et al.Informatics in Medicine Unlocked|June 26, 2023
Corrigendum to ‟Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulationsˮ [Inform. Med. Unlocked 23 (2021) 1-9/100541]Soodeh Mahdian, Mahboobeh Zarrabi, Yunes Panahi, et al.Journal of Molecular Modeling|March 29, 2022
In silico evidence for prednisone and progesterone efficacy in recurrent implantation failure treatmentSoodeh Mahdian, Mahboobeh Zarrabi, Ashraf Moini, et al.Journal of Molecular Modeling|May 28, 2020
In silico identification of new inhibitors for βeta-2-glycoprotein I as a major antigen in antiphospholipid antibody syndromeSoodeh Mahdian, Mahboobeh Zarrabi, Ashraf Moini, et al.Pageof 2